Table of Content

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Vietnam Over the counter (OTC) drugs (OTC) Drugs Market
4. Executive Summary
5. Voice of Customers
6. Vietnam Over the counter (OTC) drugs (OTC) Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. Vietnam Cough, Cold and Flu Over the counter (OTC) drugs (OTC) Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
8. Vietnam Vitamins, Mineral and Supplements (VMS) Over the counter (OTC) drugs (OTC) Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Route of Administration
8.2.2. By Dosage Form
8.2.3. By Distribution Channel
9. Vietnam Analgesics Over the counter (OTC) drugs (OTC) Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Route of Administration
9.2.2. By Dosage Form
9.2.3. By Distribution Channel
10. Vietnam Gastrointestinal Over the counter (OTC) drugs (OTC) Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Route of Administration
10.2.2. By Dosage Form
10.2.3. By Distribution Channel
11. Vietnam Dermatology Over the counter (OTC) drugs (OTC) Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Route of Administration
11.2.2. By Dosage Form
11.2.3. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Policy & Regulatory Landscape
15. Vietnam Economic Profile
16. Competitive Landscape
16.1. Competition Outlook
16.2. Company Profiles
16.2.1. Sanofi-Aventis Vietnam Company
16.2.2. GlaxoSmithKline Vietnam
16.2.3. Reckitt Benckiser Vietnam
16.2.4. Imexpharm Pharmaceutical Joint Stock Company
16.2.5. DHG Pharmaceutical Joint Stock Company
16.2.6. Traphaco Joint Stock Company
16.2.7. Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company
16.2.8. Vimedimex Medi-Pharma Joint Stock Company
16.2.9. Vietnam Pharmaceutical Corporation
16.2.10. Ha Tay Pharmaceutical Joint Stock Company
17. Strategic Recommendations